Yahoo Web Search

Search results

    • J&J targets 2024 for Ottava FDA filing

      J&J targets 2024 for Ottava FDA filing

      MedTech Dive via Yahoo Finance· 6 months ago

      The company expects to file a submission for an investigational device exemption in the second half of 2024 that will allow it to begin clinical trials...

    • 5 takeaways from J&J’s investor day

      5 takeaways from J&J’s investor day

      MedTech Dive via Yahoo Finance· 5 months ago

      After spinning out its consumer health business, Johnson & Johnson has no plans to do the same with its medtech business. J&J CEO Joaquin Duato told...